XL-R3TA 25mg

Description

XL-R3TA is a triple-agonist research peptide that engages GLP-1, GIP, and glucagon receptor pathways in controlled in-vitro studies.

XL-R3TA — 25 mg | Research Use Only

This listing provides a research-grade, lyophilised peptide for cell-based and biochemical model systems. Investigations focus on molecular mechanisms and assay readouts only.
For laboratory research only. Not for human use.

Key features

• Triple-agonist (GLP-1/GIP/GCGR) (GLP-3) peptide analogue for in-vitro receptor-signalling and SAR studies.
• Supplied as a lyophilised solid for straightforward handling and storage.
• Unit size: 25 mg per vial.
• Each batch released after stringent internal quality checks.

Specifications for XL-R3TA

• Product name: XL-R3TA
• Synonyms: XL R3TA (research code)
• Class: Peptide analogue (research use)
• Form: Lyophilised powder
• Unit size: 25 mg
• Appearance: White to off-white solid
• Note: Counter-ion/hydration state may vary. Refer to the vial label for lot-specific details.

Handling & storage of XL-R3TA

1. Storage (dry): Keep vials at 2–8 °C, protected from light and moisture.
2. Reconstitution: For step-by-step guidance, see our internal guide:
   Reconstituting & Storage.
3. After reconstitution: Store at 2–8 °C, protect from light, use aliquots to reduce handling, and avoid repeated temperature cycling.
4. Compatibility: Use only within research protocols that follow your lab’s SOPs and local regulations.

Looking for complementary materials? See
Bacteriostatic Water 10 ml and related mitochondrial/metabolic companions such as
MOTS-c 10 mg and
NAD+.

About XL-R3TA in research

Researchers employ XL-R3TA to examine peptide–receptor engagement across GLP-1, GIP, and glucagon pathways (GLP3), map downstream second-messenger responses, and compare potency/selectivity across assay systems—exclusively in controlled, non-clinical in-vitro environments.

Synthesis & quality

Manufactured via controlled, validated peptide-synthesis processes to deliver high purity and lot-to-lot consistency. Each batch undergoes identity, purity, and appearance checks before release.

Legal & safety

XL Peptides supplies materials strictly for laboratory research. Products are not medications, foods, supplements, or cosmetics; not for human or veterinary use. By purchasing, you confirm you are a qualified researcher and will handle the material in line with your institution’s policies and applicable laws.

FAQs about XL-R3TA

What is XL-R3TA?
A research-grade triple-agonist peptide analogue used to study GLP-1/GIP/glucagon receptor pharmacology and second-messenger signalling in vitro.

How should I store the peptide?
Keep lyophilised vials at 2–8 °C away from light and moisture. After reconstitution, store at 2–8 °C, protect from light, and avoid repeated temperature cycling.

Where can I find reconstitution guidance?
See our step-by-step internal guide:
Reconstituting & Storage.

Is this product for human use?
No. This material is for research only and is not intended for human consumption or clinical applications.

External resources for researchers

• PubMed — GLP-1/GIP/glucagon triple-agonist (search)
• UniProt — GLP1R (human)
• UniProt — GIPR (human)
• UniProt — GCGR (human)
• KEGG — Glucagon signalling pathway

Related research products

• MOTS-c 10 mg
• NAD+
• Bacteriostatic Water 10 ml